Benjamin A Miko1, Suma S Kamath2, Bevin A Cohen3, Christie Jeon4, Haomiao Jia5, Elaine L Larson3. 1. Division of Infectious Diseases, Department of Medicine. 2. Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, College of Physicians and Surgeons. 3. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York. 4. Center for Cancer Prevention and Control Research, Department of Health Policy and Management, University of California, Los Angeles. 5. Department of Biostatistics, Mailman School of Public Health, Columbia University, New York.
Abstract
BACKGROUND: Children with short bowel syndrome (SBS) suffer from strikingly high rates of morbidity and mortality, due in part to their susceptibility to life-threatening infectious diseases. Few large, multisite studies have evaluated patient-specific factors associated with bacteremia in hospitalized children with and without SBS. METHODS: We conducted a case-control study to examine the epidemiological associations between SBS and bloodstream infections (BSI) in hospitalized children. Pediatric BSI cases and controls were selected from a prospective cohort study conducted at 3 New York City hospitals. RESULTS: Among 40 723 hospital admissions of 30 179 children, 1047 diagnoses of BSI were identified. A total of 64 children had a diagnosis of SBS. BSI was identified frequently among hospitalizations for children admitted with SBS (n = 207/450, 46%) compared to hospitalizations for children without the condition (n = 840/40 273, 2.1%, P < .001). While this population represented only 0.2% of our overall cohort, it accounted for nearly 20% of all hospital admissions with BSI. Multivariable analysis identified 8 factors significantly associated with pediatric hospitalizations with BSI. These included a diagnosis of SBS (odds ratio [OR] 19.0), ages 1-5 years (OR 1.33), presence of a non-Broviac-Hickman central venous catheter (OR 6.36), immunosuppression (OR 0.53), kidney injury (OR 6.67), organ transplantation (OR 4.44), admission from a skilled nursing facility (OR 2.66), and cirrhosis (OR 7.23). CONCLUSIONS: While several clinical characteristics are contributory to the risk of BSI in children, SBS remains the single strongest predictor. Further research into the mediators of this risk will be essential for the development of prevention strategies for this vulnerable population.
BACKGROUND:Children with short bowel syndrome (SBS) suffer from strikingly high rates of morbidity and mortality, due in part to their susceptibility to life-threatening infectious diseases. Few large, multisite studies have evaluated patient-specific factors associated with bacteremia in hospitalized children with and without SBS. METHODS: We conducted a case-control study to examine the epidemiological associations between SBS and bloodstream infections (BSI) in hospitalized children. Pediatric BSI cases and controls were selected from a prospective cohort study conducted at 3 New York City hospitals. RESULTS: Among 40 723 hospital admissions of 30 179 children, 1047 diagnoses of BSI were identified. A total of 64 children had a diagnosis of SBS. BSI was identified frequently among hospitalizations for children admitted with SBS (n = 207/450, 46%) compared to hospitalizations for children without the condition (n = 840/40 273, 2.1%, P < .001). While this population represented only 0.2% of our overall cohort, it accounted for nearly 20% of all hospital admissions with BSI. Multivariable analysis identified 8 factors significantly associated with pediatric hospitalizations with BSI. These included a diagnosis of SBS (odds ratio [OR] 19.0), ages 1-5 years (OR 1.33), presence of a non-Broviac-Hickman central venous catheter (OR 6.36), immunosuppression (OR 0.53), kidney injury (OR 6.67), organ transplantation (OR 4.44), admission from a skilled nursing facility (OR 2.66), and cirrhosis (OR 7.23). CONCLUSIONS: While several clinical characteristics are contributory to the risk of BSI in children, SBS remains the single strongest predictor. Further research into the mediators of this risk will be essential for the development of prevention strategies for this vulnerable population.
Entities:
Keywords:
bacteriology; bloodstream infections; health care–associated infections
Authors: Conrad R Cole; Juliana C Frem; Brian Schmotzer; Andrew T Gewirtz; Jonathan B Meddings; Benjamin D Gold; Thomas R Ziegler Journal: J Pediatr Date: 2010-02-20 Impact factor: 4.406
Authors: Conrad R Cole; Nellie I Hansen; Rosemary D Higgins; Edward F Bell; Seetha Shankaran; Abbot R Laptook; Michele C Walsh; Ellen C Hale; Nancy S Newman; Abhik Das; Barbara J Stoll Journal: J Pediatr Date: 2011-08-15 Impact factor: 4.406
Authors: Allison F Linden; Chase Corvin; Keva Garg; Richard R Ricketts; A Alfred Chahine Journal: Pediatr Surg Int Date: 2017-06-27 Impact factor: 1.827
Authors: Selena Hariharan; Ethan A Mezoff; Christopher E Dandoy; Yue Zhang; Janis Chiarenzelli; Misty L Troutt; Jean Simpkins; Mary Dewald; Kim Klotz; Adam G Mezoff; Conrad R Cole Journal: Pediatr Qual Saf Date: 2018-07-20